These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7514903)

  • 1. Expression of CD33, CD38, and HLA-DR on CD34+ human fetal liver progenitors with a high proliferative potential.
    Muench MO; Cupp J; Polakoff J; Roncarolo MG
    Blood; 1994 Jun; 83(11):3170-81. PubMed ID: 7514903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FLK-2/FLT-3 ligand regulates the growth of early myeloid progenitors isolated from human fetal liver.
    Muench MO; Roncarolo MG; Menon S; Xu Y; Kastelein R; Zurawski S; Hannum CH; Culpepper J; Lee F; Namikawa R
    Blood; 1995 Feb; 85(4):963-72. PubMed ID: 7531516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic and functional characterization of committed and primitive myeloid and lymphoid hematopoietic precursors in human fetal liver.
    Roy V; Miller JS; Verfaillie CM
    Exp Hematol; 1997 May; 25(5):387-94. PubMed ID: 9168060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferative responses to interleukin-3 and granulocyte colony-stimulating factor distinguish a minor subpopulation of CD34-positive marrow progenitors that do not express CD33 and a novel antigen, 7B9.
    Litzow MR; Brashem-Stein C; Andrews RG; Bernstein ID
    Blood; 1991 Jun; 77(11):2354-9. PubMed ID: 1710150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional differences between CD38- and DR- subfractions of CD34+ bone marrow cells.
    Rusten LS; Jacobsen SE; Kaalhus O; Veiby OP; Funderud S; Smeland EB
    Blood; 1994 Sep; 84(5):1473-81. PubMed ID: 7520773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic characterization of normal and CML CD34-positive cells: only the most primitive CML progenitors include Ph-neg cells.
    De Fabritiis P; Dowding C; Bungey J; Chase A; Angus G; Szydlo R; Goldman JM
    Leuk Lymphoma; 1993 Sep; 11(1-2):51-61. PubMed ID: 7693107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic and functional characterization of long-term culture-initiating cells present in peripheral blood progenitor collections of normal donors treated with granulocyte colony-stimulating factor.
    Prosper F; Stroncek D; Verfaillie CM
    Blood; 1996 Sep; 88(6):2033-42. PubMed ID: 8822922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the growth properties of CD34+, CD38- bone marrow progenitors during human fetal development.
    Waller EK; Huang S; Terstappen L
    Blood; 1995 Jul; 86(2):710-8. PubMed ID: 7541673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candidate hematopoietic stem cells from fetal tissues, umbilical cord blood vs. adult bone marrow and mobilized peripheral blood.
    Huang S; Law P; Young D; Ho AD
    Exp Hematol; 1998 Nov; 26(12):1162-71. PubMed ID: 9808056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional differences between subpopulations of mobilized peripheral blood-derived CD34+ cells expressing different levels of HLA-DR, CD33, CD38 and c-kit antigens.
    Sakabe H; Ohmizono Y; Tanimukai S; Kimura T; Mori KJ; Abe T; Sonoda Y
    Stem Cells; 1997; 15(1):73-81. PubMed ID: 9007225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flt3 ligand enhances the yield of primitive cells after Ex vivo cultivation of CD34+ CD38dim cells and CD34+ CD38dim CD33dim HLA-DR+ cells.
    Dooley DC; Xiao M; Oppenlander BK; Plunkett JM; Lyman SD
    Blood; 1997 Nov; 90(10):3903-13. PubMed ID: 9354657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD34+/CD33- cells reselected from macrophage inflammatory protein 1 alpha+interleukin-3--supplemented "stroma-noncontact" cultures are highly enriched for long-term bone marrow culture initiating cells.
    Verfaillie CM; Miller JS
    Blood; 1994 Sep; 84(5):1442-9. PubMed ID: 7520771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid-lymphoid initiating cells (ML-IC) are highly enriched in the rhodamine-c-kit(+)CD33(-)CD38(-) fraction of umbilical cord CD34(+) cells.
    Liu H; Verfaillie CM
    Exp Hematol; 2002 Jun; 30(6):582-9. PubMed ID: 12063025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term generation and expansion of human primitive hematopoietic progenitor cells in vitro.
    Srour EF; Brandt JE; Briddell RA; Grigsby S; Leemhuis T; Hoffman R
    Blood; 1993 Feb; 81(3):661-9. PubMed ID: 7678996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of CD34+ peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony-stimulating factor.
    Tjønnfjord GE; Steen R; Evensen SA; Thorsby E; Egeland T
    Blood; 1994 Oct; 84(8):2795-801. PubMed ID: 7522643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flt3 ligand induces proliferation of quiescent human bone marrow CD34+CD38- cells and maintains progenitor cells in vitro.
    Shah AJ; Smogorzewska EM; Hannum C; Crooks GM
    Blood; 1996 May; 87(9):3563-70. PubMed ID: 8611678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of interleukin-3, interleukin-7, interleukin 15, and granulocyte-macrophage colony-stimulating factor in the generation of natural killer and B cells from primitive human fetal liver progenitors.
    Muench MO; Humeau L; Paek B; Ohkubo T; Lanier LL; Albanese CT; Bárcena A
    Exp Hematol; 2000 Aug; 28(8):961-73. PubMed ID: 10989197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of c-kit receptor-expressing cells from bone marrow, peripheral blood, and fetal liver: functional properties and composite antigenic profile.
    Papayannopoulou T; Brice M; Broudy VC; Zsebo KM
    Blood; 1991 Sep; 78(6):1403-12. PubMed ID: 1715789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells.
    To LB; Haylock DN; Dowse T; Simmons PJ; Trimboli S; Ashman LK; Juttner CA
    Blood; 1994 Nov; 84(9):2930-9. PubMed ID: 7524760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.